F-1/A: Park Ha Biological Seeks $4M in Best-Efforts Offering

Park Ha Biological Technology Co., Ltd. filed an F-1/A registration statement for a best-efforts public offering of up to 11,428,571 ordinary shares and accompanying warrants, aiming to raise approximately $3.5 million for store expansion.

Summary

• Offering up to 11,428,571 ordinary shares and up to 11,428,571 common warrants at an assumed public offering price of $0.35 per share and accompanying warrant.
• Also offering up to 11,428,571 pre-funded warrants in lieu of ordinary shares for certain purchasers, with an exercise price of $0.001 per share.
• Estimated net proceeds from the offering are approximately $3.5 million, intended for the expansion of directly operated stores.
• Reported a net loss of $19,835,994 for the six months ended April 30, 2025, a significant decline from a net income of $48,900 for the same period in 2024.
• Total revenue increased by $386,269 to $1,239,197 for the six months ended April 30, 2025, from $852,928 for the six months ended April 30, 2024.
• Net income decreased by $373,481 to $478,561 for the fiscal year ended October 31, 2024, from $852,042 for the fiscal year ended October 31, 2023.
• Received a Nasdaq notice on September 2, 2025, for not meeting the $1 minimum bid price requirement, with a compliance period until March 2, 2026.
• The number of franchisees decreased from 45 on October 31, 2024, to 39 on April 30, 2025.
• The company is a Cayman Islands holding company with all operations conducted in China through its PRC Subsidiaries.
• Ms. Xiaoqiu Zhang, the founder, Chairperson, and CEO, owns over 50% of the total voting power, classifying the company as a controlled company under Nasdaq rules.

Sentiment

Score: 3

Explanation: The filing reveals a significant net loss, a decrease in net income year-over-year, a decline in franchisee numbers, and a Nasdaq minimum bid price deficiency notice, all indicating substantial operational and financial challenges despite some revenue growth. The 'best-efforts' offering also adds uncertainty to the capital raise.

Positives

• Total revenue increased by $386,269 to $1,239,197 for the six months ended April 30, 2025, from $852,928 for the six months ended April 30, 2024.
• The company has a comprehensive quality assurance program and rigorous on-site audit program for suppliers to ensure product quality and safety.
• A strong and diversified management team with over ten years of industry experience in beauty, fashion, retail, and internet sectors.
• Implemented an innovative social marketing model and Online-to-Offline (O2O) business model to engage customers and attract franchisees.
• Established official accounts on popular Chinese short video platforms like Douyin, RED, and WeChat Video, enhancing brand popularity.
• Holds 21 registered trademarks, 12 registered patents, 5 registered copyrights, and 1 domain name in China.

Negatives

• Reported a significant net loss of $19,835,994 for the six months ended April 30, 2025, a substantial deterioration from a net income of $48,900 in the prior comparable period.
• Net income decreased by $373,481 to $478,561 for the fiscal year ended October 31, 2024, from $852,042 for the fiscal year ended October 31, 2023.
• Received a Nasdaq notice on September 2, 2025, for failing to meet the $1 minimum bid price requirement, indicating potential delisting risk.
• The number of franchisees decreased from 45 on October 31, 2024, to 39 on April 30, 2025, suggesting challenges in its franchise growth strategy.
• The offering is on a 'best-efforts basis' with no minimum amount, meaning the company may not raise sufficient capital to fund its business plans.
• No established public trading market for Common Warrants or Pre-Funded Warrants, and no intention to list them, limiting liquidity for these securities.
• New investors face significant dilution of $0.18 per Ordinary Share.
• Reliance on a limited number of suppliers (six suppliers accounted for 10% or more of total purchases for H1 2025) creates supply chain concentration risk.
• Reliance on a few major customers (two customers accounted for 10% or more of total revenue for H1 2024 and FY 2024/2023).
• Does not own the formulas for its products, relying on third-party manufacturers, which could pose a risk if competitors engage the same manufacturers.
• Does not maintain any insurance to cover assets, operations, or business interruptions.

Risks

• Funds or assets in the PRC or Hong Kong may not be available for use outside due to PRC government restrictions and limitations on cash or asset transfers.
• Uncertainties with the PRC legal system, including rapid changes in laws and regulations, could materially adversely affect the business.
• The PRC government may intervene or influence operations at any time, potentially limiting the ability to offer securities or causing their value to decline.
• Approval or filing with the CSRC or other PRC regulatory agencies may be required to maintain listing status or conduct future offshore securities offerings.
• The Holding Foreign Companies Accountable Act (HFCAA) and continued U.S. regulatory focus may adversely affect the market price of Ordinary Shares and could lead to delisting.
• Increased oversight by the Cyberspace Administration of China (CAC) over data security, particularly for companies seeking foreign listings, could impact the business.
• Reliance on dividends and other distributions from PRC Subsidiaries for cash and financing, with potential limitations on their ability to pay dividends.
• Difficulties for overseas regulators to conduct investigations or collect evidence within China.
• Fluctuations in currency exchange rates could have a material and adverse effect on investment value.
• Governmental regulations on currency conversion may limit the ability to utilize revenues effectively.
• Changes in PRC political, economic, and governmental policies may adversely impact the business.
• Failure to comply with PRC laws and regulations related to labor and employee benefits may result in penalties or additional costs.
• The PRC Labor Contract Law, increased labor costs, or other factors affecting the labor force in the PRC may adversely affect business and results of operations.
• PRC regulation of loans to, and direct investment in, PRC entities by offshore holding companies may delay or prevent the use of financing proceeds for PRC Subsidiaries.
• Certain PRC regulations may make it more difficult to pursue growth through acquisitions.
• Potential classification as a PRC resident enterprise for PRC enterprise income tax purposes could result in unfavorable tax consequences.
• PRC regulations relating to offshore investment activities by PRC residents may limit PRC Subsidiaries' ability to change registered capital or distribute profits.
• The beauty industry is highly competitive, and an inability to compete effectively may lead to market share loss.
• Success is dependent on the continued popularity of products and the ability to anticipate and respond to changes in industry trends and consumer preferences.
• Business depends on the quality, effectiveness, and safety of products; any loss of consumer confidence could tarnish the brand.
• Inability to provide superior customer experiences could materially and adversely affect the business and reputation.
• Reliance on a limited number of suppliers for raw materials and ingredients increases the risk of supply chain disruptions.
• Significant portion of revenue derived from a few major customers, making the company vulnerable to changes in their demand.
• Success depends on the implementation of the franchise business model, and growth through franchising may not occur as rapidly as anticipated.
• The Chairperson and CEO, Ms. Xiaoqiu Zhang, has significant influence, and her interests may not always align with those of other shareholders.
• As an emerging growth company and foreign private issuer, the company is eligible for reduced reporting requirements, which may provide less protection to investors.
• The trading price of the Ordinary Shares is likely to be volatile.
• Failure to maintain an effective system of internal control over financial reporting could lead to inaccurate financial results or fraud.
• Risk of delisting from Nasdaq due to not meeting the $1 minimum bid price requirement.
• The 'best efforts' nature of the offering means no minimum number or dollar amount of securities is required to be sold, potentially resulting in insufficient capital.
• No public market for the Common Warrants or Pre-Funded Warrants, limiting their liquidity.
• Warrants are speculative in nature and do not confer shareholder rights until exercised.
• Significant holders may not be permitted to exercise warrants if it results in beneficial ownership exceeding 4.99% (or 9.99%).
• The company will not receive any meaningful additional funds upon the exercise of Pre-Funded Warrants or cashless exercise of Common Warrants.
• Reliance on third-party manufacturers for product formulas means the company does not own the formulas, posing a risk if competitors use the same manufacturers.
• Lack of insurance to cover assets, operations, and business interruptions.

Future Outlook

The company intends to use the net proceeds from this offering for the expansion of its directly operated stores. It plans to strengthen the development of its own products, improve training practices (including opening vocational training schools in inland and western China), enhance social media-based sales and marketing capabilities, improve supply chain capacity by partnering with additional third-party manufacturers and establishing warehouse/distribution centers, and seek strategic investments, acquisitions, and other cooperation opportunities in the beauty industry. The company also plans to launch new brands targeting male groups in the future.

Management Comments

• We aim to provide cost-effective solutions to skin problems and improve the confidence of women in need of skin treatment.
• We believe our competitive advantages, including an innovative social marketing model, stable supply chain system, and strong management team, will enable us to maintain and further improve our market position.
• Our CEO and CTO, with over ten years of industry experience, play essential roles in reaching out to potential customers, leveraging their profound understanding of the beauty industry and commitment to our mission.

Industry Context

The company operates in the highly competitive beauty market in China, facing established multinational and domestic brands, as well as smaller niche brands. Its strategy of leveraging social media platforms (Douyin, RED, WeChat Video) and an Online-to-Offline (O2O) business model aligns with evolving Chinese consumer preferences for digital engagement and intimate product experiences. The focus on problematic and sensitive skin, coupled with a franchise model, is a strategic approach to differentiate and expand market presence amidst intense competition, where larger players benefit from economies of scale.

Comparison to Industry Standards

• The company competes with larger, more established brands like Fanwenhua, DR PLANT, and Beauty Farm, each having over 100 franchisees nationwide, significantly more than Park Ha's 39 franchisees as of April 30, 2025.
• Larger competitors often benefit from economies of scale, allowing them to produce goods at lower costs per unit, which could give them pricing advantages that Park Ha may struggle to match while maintaining profitability.
• Park Ha's innovative social marketing model and O2O strategy are competitive differentiators in the Chinese beauty market, where digital engagement and personalized customer experiences are increasingly important, aligning with broader industry trends.

Management Changes

Corporate Governance

Legal Proceedings

• No legal or administrative proceedings are mentioned as having a material adverse impact on the business, balance sheets, or results of operations and cash flows in this specific filing, other than general references to risks of litigation.

Related Party Transactions

• No detailed related party transactions are disclosed in this specific filing; it refers to the 2024 Annual Report and a Form 6-K filing for such information.

Stakeholder Impact

• Shareholders: Face potential dilution from the offering, significant risk of delisting from Nasdaq due to bid price deficiency, and volatility in share price. The substantial net loss could negatively impact investment value. Warrants offered have limited liquidity.
• Employees: The company has increased its full-time employee count to 38 as of April 30, 2025, and has adopted new share incentive plans (2025 and Amended 2025) to provide equity incentives, indicating a focus on talent attraction and retention. Plans for vocational training schools could also benefit employee development.
• Customers: The company aims to provide high-quality products and services, expand directly operated stores, and enhance digital engagement through social media and an O2O model, potentially leading to improved customer experience and product offerings.
• Franchisees: The number of franchisees has decreased, indicating challenges in this segment. However, the company continues to offer support through training and a stable supply chain, along with incentives like cash subsidies for renovation and advertising.
• Creditors: The significant net loss and uncertainty of capital raise from the 'best-efforts' offering could raise concerns regarding the company's ability to meet future obligations.

Next Steps

• Regain compliance with Nasdaq's $1 minimum bid price requirement, potentially through a share consolidation, by March 2, 2026.
• Expand directly operated stores using the net proceeds from the offering.
• Strengthen the development of proprietary skincare products, including expanding partnerships with scientific research institutions.
• Improve training practices by opening vocational training schools in inland and western China.
• Enhance social media-based sales and marketing capabilities on platforms like Douyin, RED, and WeChat Video.
• Improve supply chain capacity by partnering with additional third-party manufacturers and establishing warehouse/distribution centers.
• Evaluate and selectively seek strategic alliances, investment, and acquisition opportunities in the beauty industry across China.
• Launch new brands targeting male consumer groups.
• File with the CSRC within three business days after the completion of this offering, as required by the Trial Measures.

Key Dates

Recommendation

The company faces significant financial and operational challenges, including a substantial net loss of nearly $20 million in the most recent six-month period, a decline in net income year-over-year, and a Nasdaq delisting notice for failing to meet the minimum bid price. The 'best-efforts' nature of the capital raise introduces uncertainty regarding the actual funds to be secured, which are critical for its stated expansion plans. The decrease in franchisee numbers and reliance on third-party product formulas add further risks. While revenue increased, the overall financial health and regulatory compliance issues present a highly unfavorable investment outlook.

Keywords

Skincare, Biotechnology, China, SEC Filing, F-1/A, Public Offering, Nasdaq, Warrants, Franchise, Cosmetics, Beauty Industry, Risk Factors, Corporate Governance, Financial Performance, Capital Raise, Emerging Growth Company, Foreign Private Issuer, PRC Regulations, Supply Chain, Marketing, R&D